A model-based systems engineering approach to end-to-end pharmaceutical manufacturing of liquid
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40122C00122
- Awardee
-
National Institute For Pharmaceutical Technology & Education Inc. UEI RKVKGV1CJDB8
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $4,262,210
Award facts
- Opportunity
-
- FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Solicitation · FDABAA2200123 · Posted Nov 10, 2021
- Contract value 85% obligated
-
- $4,262,209.79 Current, with exercised options
- $4,999,953.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55414, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,560,691 | |
| Original award | $2,701,519 |
About this award
This is a $4,999,953.00 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to the National Institute for Pharmaceutical Technology & Education Inc. (Nipte), a non-profit organization. The contract was awarded under the FDA's Broad Agency Announcement mechanism to support research and development on a "model-based systems engineering approach to end-to-end pharmaceutical manufacturing of liquid" products. This contract is not associated with a set-aside. Nipte has previously received other FDA contracts and grants to advance regulatory science and pharmaceutical technology, including work on continuous drug manufacturing and biosimilar characterization.
Quick answers
Who was awarded contract 75F40122C00122?
75F40122C00122 was awarded to National Institute For Pharmaceutical Technology & Education Inc. by Food and Drug Administration (Department of Health and Human Services) on September 14, 2022.
How much is contract 75F40122C00122 worth?
The government has obligated $4,262,210 on 75F40122C00122. Its potential value, with all options, is $4,999,953.
Was contract 75F40122C00122 competed?
The extent of competition for 75F40122C00122 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award